Presentation is loading. Please wait.

Presentation is loading. Please wait.

Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover.

Similar presentations


Presentation on theme: "Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover."— Presentation transcript:

1 Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover study  N. Mittman, R. Khanna, S. Rani, J. Chattopadhyay, M.M. Avram  Kidney International  Volume 70, Pages S64-S67 (December 2006) DOI: /sj.ki Copyright © 2006 International Society of Nephrology Terms and Conditions

2 Figure 1 Spearman rank correlation between biointact PTH values during paricalcitol and calcitriol treatment. (Correlation coefficient r=0.5, P<0.0001). Kidney International  , S64-S67DOI: ( /sj.ki ) Copyright © 2006 International Society of Nephrology Terms and Conditions

3 Figure 2 Number of missed doses during paricalcitol and calcitriol treatment. (P<0.001) Kidney International  , S64-S67DOI: ( /sj.ki ) Copyright © 2006 International Society of Nephrology Terms and Conditions


Download ppt "Paricalcitol therapy for secondary hyperparathyroidism in patients on maintenance hemodialysis previously treated with calcitriol: A single-center crossover."

Similar presentations


Ads by Google